SCHEMBL7182974

SCHEMBL7182974

CCCOc1cc(OCCC)c(C=CC(=O)c2ccc(N)cc2)cc1C

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.49
PTPN1 P18031 2/20 0.49
CTSL P07711 1/20 0.49
CTSB P07858 1/20 0.49
ABCG2 Q9UNQ0 3/20 0.48
CYP1A1 P04798 2/20 0.46
CYP1B1 Q16678 2/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
KRAS P01116 1/20 0.45
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GAA P10253 1/20 0.44
BCHE P06276 1/20 0.43
CYP3A4 P08684 1/20 0.43
AR P10275 1/20 0.42
CAPN1 P07384 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7176964 0.94 DPP4 (0.51) DPP4PTPN1CTSLCTSBABCG2
SCHEMBL7185991 0.91 PTPN1 (0.56) DPP4PTPN1CTSLCTSBABCG2
SCHEMBL7185985 0.91 PTPN1 (0.56) DPP4PTPN1CTSLCTSBABCG2
SCHEMBL7191596 0.90 MAPT (0.51) DPP4PTPN1CTSLCTSBABCG2
SCHEMBL7191601 0.90 MAPT (0.51) DPP4PTPN1CTSLCTSBABCG2
SCHEMBL7180998 0.89 ABCG2 (0.57) DPP4PTPN1CTSLCTSBABCG2
SCHEMBL9111754 0.89 DPP4 (0.61) DPP4PTPN1ABCG2CYP1A1CYP1B1
SCHEMBL9112659 0.87 DPP4 (0.56) DPP4PTPN1ABCG2CYP1A1CYP1B1
SCHEMBL9113194 0.87 DPP4 (0.59) DPP4PTPN1ABCG2CYP1A1CYP1B1
SCHEMBL9112573 0.87 DPP4 (0.59) DPP4PTPN1ABCG2CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed